July 24, 2009 — The US Food and Drug Administration (FDA) has approved a 0.45% ophthalmic solution of the nonsteroidal anti-inflammatory drug ketorolac tromethamine (Acuvail, Allergan, Inc) for the ...

Please provide your email address to receive an email when new articles are posted on . We interrupt this well-designed linear discussion of dry eye syndrome to bring you an important announcement: ...

A South Florida drug maker recalled 199,584 bottles of three ophthalmic solutions because of a “lack of assurance on sterility.” That’s from FDA alert that the recalls from Apotex’s Weston facility ...